| BSE: 535022 | Sector: Health care |
| NSE: BETA | ISIN Code: INE351Y01019 |
| BSE 05:30 | 01 Jan | Beta Drugs Ltd |
| NSE 00:00 | 26 May | 44.20 |
(%) |
OPEN
43.30 |
HIGH
44.20 |
LOW
43.30 |
| OPEN | |
| PREVIOUS CLOSE | |
| VOLUME | |
| 52-Week high | 0.00 |
| 52-Week low | 0.00 |
| P/E | |
| Mkt Cap.(Rs cr) | 0 |
| Buy Price | |
| Buy Qty | |
| Sell Price | |
| Sell Qty |
8.28 pm | 26 May 2020 | Business Standard
The company saw its total consolidated revenue in Q4FY20 at Rs 1961 crore, up by a marginal 4.69 per cent over Rs 1873 crore in Q4FY19
4.08 pm | 26 May 2020 | Business Standard
All that happened in the markets today
1.49 pm | 26 May 2020 | Agencies
Drugmakers across the world have been rushing to develop a treatment or vaccine for the fast-spreading coronavirus, which has infected 5.5 million peo...
8.20 am | 26 May 2020 | Business Standard
Technical Calls by Gaurav Garg, Head of Research at CapitalVia Global Research Limited- Investment Advisor
12.26 am | 24 May 2020 | Business Standard
Medical devices industry has potential to attract Rs 70,000 crore in 5 years
12.26 am | 24 May 2020 | Business Standard
Medical devices industry has potential to attract Rs 70,000 crore in 5 years
4.17 pm | 22 May 2020 | Business Standard
All that happened in the markets today
8.12 am | 22 May 2020 | Business Standard
Long build-up was seen in the Glenmark Futures yesterday
1.37 am | 22 May 2020 | Business Standard
Analysts estimate 38 per cent annual growth in earnings during FY20-22
4.05 pm | 21 May 2020 | Business Standard
All that happened in the markets today
2.04 pm | 21 May 2020 | Business Standard
The stock of Syngene International has soared 24 per cent during the past month, as against a 2 per cent rise in the S&P BSE Sensex.
2.04 pm | 21 May 2020 | Business Standard
The stock of Syngene International has soared 24 per cent during the past month, as against a 2 per cent rise in the S&P BSE Sensex.
12.54 pm | 21 May 2020 | Business Standard
Of the total 50 companies from the Nifty index, FPIs has reduced their holdings in 45 companies during the recently concluded quarter
12.06 pm | 21 May 2020 | Business Standard
Favipiravir is manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and was approved for use as an anti-flu drug in th...
11.05 am | 21 May 2020 | Business Standard
One needs to first gauge the overall trend by correlating different indicators and chart patterns with price momentum
8.15 am | 21 May 2020 | Business Standard
Technical Calls by Gaurav Garg, Head of Research at CapitalVia Global Research Limited- Investment Advisor
2.20 am | 21 May 2020 | Business Standard
Ranitidine was a $9 million business for Strides in the first half of FY20
11.41 pm | 19 May 2020 | Business Standard
Once the late stage trials begin, the company simultaneously will start working on the global manufacturing capabilities.
10.07 am | 19 May 2020 | Business Standard
Favipiravir is under trial in many countries as a potential treatment for Covid-19
12.22 am | 19 May 2020 | Agencies
The company had posted a net profit of Rs 146.81 crore for the same period previous fiscal, GlaxoSmithKline Pharmaceuticals said in a BSE filing.
